MetaADEDB 2.0 @ LMMD
naftopidil
(HRRBJVNMSRJFHQ-UHFFFAOYSA-N)
Structure
SMILES
COc1ccccc1N1CCN(CC1)CC(COc1cccc2c1cccc2)O
Type(s)
Investigational
Molecular Formula:
C24H28N2O3
Molecular Weight:
392.491
Log P:
3.4132
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
45.17
CAS Number(s):
57149-07-2
Synonym(s)
1.
naftopidil
2.
1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol
External Link(s)
MeSHC064357
PubChem Compound4418
BindingDB50086661
50773
ChEBI31891
CHEMBLCHEMBL142635
DrugBankDB12092
DrugCentral1873
KEGGdr:D01674
Therapeutic Target DatabaseD04DKH
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AdenitisOFFSIDES
2AgnosiaOFFSIDES
3Alanine aminotransferase abnormalOFFSIDES
4Altered state of consciousnessOFFSIDES
5AnorexiaOFFSIDES
6Anti-insulin antibody positiveOFFSIDES
7Arteriosclerosis ObliteransOFFSIDES
8Aspartate aminotransferase abnormalOFFSIDES
9Aspiration PneumoniaOFFSIDES
10BedriddenOFFSIDES
11Benign Prostatic HyperplasiaOFFSIDES
12BicytopeniaOFFSIDES
13BilomaOFFSIDES
14Bladder NeoplasmOFFSIDES
15Bladder cancer recurrentOFFSIDES
16Bladder constrictionOFFSIDES
17Bladder stenosisOFFSIDES
18BlepharospasmOFFSIDES
19Blood alkaline phosphatase increasedOFFSIDES
20Blood amylaseOFFSIDES
21Blood chloride decreasedOFFSIDES
22Blood cholesterol abnormalOFFSIDES
23Blood count abnormalOFFSIDES
24Blood creatine phosphokinase increasedOFFSIDES
25Blood creatinine increasedOFFSIDES
26Blood glucose fluctuationOFFSIDES
27Blood lactate dehydrogenase increasedOFFSIDES
28Blood potassium increasedOFFSIDES
29Blood urea increasedOFFSIDES
30Blood uric acidOFFSIDES
31Blood urine presentOFFSIDES
32Cancer PainOFFSIDES
33CandiduriaOFFSIDES
34CholangiolitisOFFSIDES
35Depressed Level of ConsciousnessOFFSIDES
36Disease ProgressionOFFSIDES
37Disseminated Intravascular CoagulationOFFSIDES
38DysuriaOFFSIDES
39EczemaOFFSIDES
40Electrocardiogram ST-T segment abnormalOFFSIDES
41EpididymitisOFFSIDES
42Erythema MultiformeOFFSIDES
43False positive tuberculosis testOFFSIDES
44HemiparesisOFFSIDES
45HypokinesiaOFFSIDES
46Hypotension, Orthostatic9639061CTD
47ImmobileOFFSIDES
48IncontinenceOFFSIDES
49Incorrect route of drug administrationOFFSIDES
50LacerationOFFSIDES
51Limb discomfortOFFSIDES
52LipaseOFFSIDES
53Lipoprotein (a) abnormalOFFSIDES
54Lymph Node TuberculosisOFFSIDES
55Lymphocyte count decreasedOFFSIDES
56MetamorphopsiaOFFSIDES
57Metastatic NeoplasmOFFSIDES
58Muscle abscessOFFSIDES
59MyelodysplasiaOFFSIDES
60Myoglobin blood increasedOFFSIDES
61Nephrotic SyndromeOFFSIDES
62Nocturia18817955CTD
63PneumothoraxOFFSIDES
64Prostatic Hyperplasia18817955CTD
65PyelonephritisOFFSIDES
66Retinal pigment epithelial tearOFFSIDES
67Retroperitoneal abscessOFFSIDES
68RhabdomyolysisOFFSIDES
69Skin lacerationOFFSIDES
70Sudden deathOFFSIDES
71Sudden onset of sleepOFFSIDES
72T-Cell LymphomaOFFSIDES
73Unevaluable eventOFFSIDES
74Urinary bladder atrophyOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.